Novartis Med Info

Free

4.3for iPhone, iPad

Novartis Pharmaceuticals Corporation

Developer

Mar 16, 2020

Update Date

Medical

Category

App Store

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Novartis Med Info Captures d'écran

iPad

iPhone

About Novartis Med Info

The Novartis Medical Information application provides health care professionals with accurate, succinct, and timely medical information. This app General Medicines and Oncology products. This application is intended for use by U.S. healthcare professionals only.

Key Features:

This app allows U.S. health care professionals to:
•View and download the latest response documents to many medical inquiries
•Use targeted search to find relevant medical information
•Submit a medical inquiry directly to Novartis through the application
•Access the latest prescribing information for Novartis products
•Report an Adverse Event for Novartis products by calling our Safety Department directly via the number listed in the app
•Speak to a Novartis Medical Information specialist by calling directly to the number listed in the app
•Email a document to themselves directly from the mobile device for further reference
•Bookmark functionality available for a response document and U.S. Prescribing Information